We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
-2.53%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$68.4M
AUM Growth
-$43.1M
(-39%)
Cap. Flow
-$41.1M
Cap. Flow
% of AUM
-60.1%
Top 10 Holdings %
Top 10 Hldgs %
2.86%
Holding
1,768
New
383
Increased
275
Reduced
163
Closed
946
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CoStar Group
CSGP
|
+$225K |
| 2 |
Delek US
DK
|
+$221K |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$215K |
| 4 |
PCH
PotlatchDeltic
PCH
|
+$201K |
| 5 |
HEES
H&E Equipment Services
HEES
|
+$200K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXO Logistics
GXO
|
+$470K |
| 2 |
Unisys
UIS
|
+$454K |
| 3 |
Schrodinger
SDGR
|
+$428K |
| 4 |
Leggett & Platt
LEG
|
+$408K |
| 5 |
Sutro Biopharma
STRO
|
+$394K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.74% |
| 2 | Industrials | 14.9% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Healthcare | 14.06% |
| 5 | Technology | 13.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
426
DELISTED
NEVRO CORP.
NVRO
| $74.7K | 0.11% |
+8,876
| New | +$94.6K |
|
427
MINISO
MNSO
$3.64B
| $74.5K | 0.11% |
3,905
+1,252
| +47% | +$27.6K |
|
|
YMAB
428
DELISTED
Y-mAbs Therapeutics
YMAB
| $74.3K | 0.11% |
+6,152
| New | +$83.1K |
|
429
Playtika
PLTK
$1.4B
| $74.3K | 0.11% |
+9,437
| New | +$74.9K |
|
430
3M
MMM
$89B
| $74.2K | 0.11% |
726
-1,269
| -64% | -$124K |
|
431
Southside Bancshares
SBSI
$1.02B
| $74.1K | 0.11% |
2,685
-608
| -18% | -$16.5K |
|
432
Addus HomeCare
ADUS
$2.14B
| $73.7K | 0.11% |
635
+205
| +48% | +$21.9K |
|
|
CNTA
433
DELISTED
Centessa Pharmaceuticals
CNTA
| $73.5K | 0.11% |
8,136
-1,500
| -16% | -$14.2K |
|
434
British American Tobacco
BTI
$132B
| $73.5K | 0.11% |
2,375
+912
| +62% | +$27.7K |
|
435
SkyWater Technology
SKYT
$1.51B
| $73.3K | 0.11% |
9,576
+6,002
| +168% | +$52.1K |
|
436
Globus Medical
GMED
$10.4B
| $73.2K | 0.11% |
+1,069
| New | +$63.9K |
|
437
JD.com
JD
$40.8B
| $72.9K | 0.11% |
2,820
+2,621
| +1,317% | +$76.9K |
|
438
Replimune Group
REPL
$814M
| $72.5K | 0.11% |
8,051
-9,653
| -55% | -$67.3K |
|
439
Viridian Therapeutics
VRDN
$2.13B
| $72.5K | 0.11% |
+5,569
| New | +$77.1K |
|
440
Pinduoduo
PDD
$118B
| $72.1K | 0.11% |
542
+341
| +170% | +$46.2K |
|
441
ADMA Biologics
ADMA
$1.92B
| $71.9K | 0.11% |
6,433
+1,693
| +36% | +$14.2K |
|
442
Exelon
EXC
$48.6B
| $71.6K | 0.1% |
2,070
-1,447
| -41% | -$53.4K |
|
443
Towne Bank
TOWN
$3.35B
| $71K | 0.1% |
2,605
+897
| +53% | +$24.1K |
|
444
Mastercard
MA
$477B
| $71K | 0.1% |
+161
| New | +$73.3K |
|
|
GTY
445
Getty Realty Corp
GTY
$2.1B
| $70.5K | 0.1% |
+2,644
| New | +$71.8K |
|
446
Hanover Insurance
THG
$7.63B
| $70.4K | 0.1% |
561
-513
| -48% | -$66.7K |
|
447
Liberty Broadband Class A
LBRDA
$4.14B
| $70.1K | 0.1% |
1,283
+1,246
| +3,368% | +$64.5K |
|
|
AAN
448
DELISTED
The Aaron's Company Inc
AAN
| $69.9K | 0.1% |
7,003
-10,381
| -60% | -$81.2K |
|
449
Cisco
CSCO
$450B
| $69.9K | 0.1% |
1,471
+19
| +1% | +$902 |
|
450
Hormel Foods
HRL
$13.9B
| $69.5K | 0.1% |
2,278
+918
| +68% | +$30.9K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q2 2024 Portfolio in Review
As of Q2 2024, EntryPoint Capital held 1,768 positions worth $68.4M, down 39% from $112M the previous quarter. Its ten largest holdings account for 2.9% of the portfolio.
EntryPoint Capital withdrew a net $41.1M in Q2 2024, closing 946 positions and reducing 163 holdings. Its most notable exit was GXO Logistics, an estimated $470K position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 13% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, EntryPoint Capital opened a new position in CoStar Group worth $197K.
- EntryPoint Capital's largest Q2 2024 buy was CoStar Group: 2,657 shares worth $197K.
- EntryPoint Capital added most to Martin Marietta Materials in Q2 2024, an estimated $181K increase.
- EntryPoint Capital's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $327K.
- EntryPoint Capital fully exited GXO Logistics in Q2 2024, selling an estimated $470K.
- EntryPoint Capital's ten largest holdings make up 2.9% of its $68.4M portfolio in Q2 2024.
- EntryPoint Capital opened 383 new positions and closed 946 in Q2 2024.
- EntryPoint Capital's portfolio value fell 39% quarter-over-quarter to $68.4M.
Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.